Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry, & Status of FDA Orange Book Exclusivities covering Brexpiprazole

Client Email

Product

Brexpiprazole
CAS 31570-97-5
U.S. EXCLUSIVITIES

Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Brexpiprazole

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

49 API Suppliers, 20 USDMF, 6 EU WC, 1 KDMF, 9 NDC API, 37 Listed Suppliers, $ API Reference Price

49 API Suppliers
20 USDMF
6 EU WC
1 KDMF
9 NDC API
37 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

25 Drugs in Development

25 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports

API Reference Price
API Exports
API Imports

INTERMEDIATES

17 API Suppliers

17 API Suppliers

FINISHED DOSAGE FORMULATIONS

118 FDF Dossiers, 91 FDA Orange Book, 6 Europe, 6 Canada, 4 Australia, 5 South Africa, 6 Listed Dossiers

118 FDF Dossiers
91 FDA Orange Book
6 Europe
6 Canada
4 Australia
5 South Africa
6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 0.25MG, TABLET;ORAL - 0.5MG, TABLET;ORAL - 1MG, TABLET;ORAL - 2MG, TABLET;ORAL - 3MG, TABLET;ORAL - 4MG

TABLET;ORAL - 0.25MG
TABLET;ORAL - 0.5MG
TABLET;ORAL - 1MG
TABLET;ORAL - 2MG
TABLET;ORAL - 3MG
TABLET;ORAL - 4MG

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 3 DKSH, 10 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 1 Aeon Procare, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 Corel Pharma Chem, 4 DFE Pharma, 5 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 29 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 15 Roquette, 7 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 2 The Dow Chemical Company, 2 Vasa Pharmachem

4 SPI Pharma
3 DKSH
10 Gangwal Healthcare
1 Nanjing Well Pharmaceutical
1 ACG Worldwide
1 Aeon Procare
5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
10 Corel Pharma Chem
4 DFE Pharma
5 Gangwal Chemicals
5 Ideal Cures Pvt Ltd
2 Ingredion Pharma Solutions
29 Kerry
3 Kima Chemical
6 Lonza Capsugel
10 Microlex e.U
1 Novo Excipients
1 Pharmatrans-Sanaq
3 Pluviaendo
2 Prachin Chemical
1 Qianhao Chemical (Hebei) Co., Ltd
1 Qualicaps
15 Roquette
7 Seppic
4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
10 Sigachi Industries
2 The Dow Chemical Company
2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

54 Fillers, Diluents & Binders, 43 Coating Systems & Additives, 24 Direct Compression, 21 Controlled & Modified Release, 13 Co-Processed Excipients, 12 Thickeners and Stabilizers, 12 Lubricants & Glidants, 11 Disintegrants & Superdisintegrants, 11 Granulation, 7 Film Formers & Plasticizers, 7 Taste Masking, 6 Chewable & Orodispersible Aids, 5 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 3 API Stability Enhancers, 2 Emulsifying Agents, 2 Rheology Modifiers, 1 Parenteral, 1 Solubilizers

54 Fillers, Diluents & Binders
43 Coating Systems & Additives
24 Direct Compression
21 Controlled & Modified Release
13 Co-Processed Excipients
12 Thickeners and Stabilizers
12 Lubricants & Glidants
11 Disintegrants & Superdisintegrants
11 Granulation
7 Film Formers & Plasticizers
7 Taste Masking
6 Chewable & Orodispersible Aids
5 Empty Capsules
5 Coloring Agents
4 Vegetarian Capsules
3 API Stability Enhancers
2 Emulsifying Agents
2 Rheology Modifiers
1 Parenteral
1 Solubilizers

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 53 NEWS #PharmaBuzz

3 DATA COMPILATION #PharmaFlow
53 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 6 Finished Drug Prices, 16 Annual Reports

1 US Medicaid Prescriptions
6 Finished Drug Prices
16 Annual Reports

MARKET PLACE

8 APIs, 1 FDF Dossiers

8 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

88 US Patents, 30 US Exclusivities

88 US Patents
30 US Exclusivities

REF. STANDARDS & IMPURITIES

8 Others

8 Others

$ API Ref.Price (USD/KG) : 10,822 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

30 All

01 30OTSUKA

filter Product Reset all filters

30 All

01 30BREXPIPRAZOLE

filter Exclusivity Expiration Date Reset all filters

30 All

01 62024-12-27

02 62026-05-10

03 62026-11-10

04 62027-05-08

05 62027-11-08

filter Exclusivity Code Reset all filters

30 All

01 6I-913

02 6M-14

03 6NPP

04 12PED

US Patents
US Exclusivities

Product Main Page

OTSUKA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BREXPIPRAZOLE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NPP

Exclusivity Expiration Date

2024-12-27

Application Number

205422

Product Number

6

Exclusivity Details

01

OTSUKA

AAPS 2024

Not Confirmed

OTSUKA

Japan

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BREXPIPRAZOLE

Exclusivity Code : NPP

Exclusivity Expiration Date : 2024-12-27

Application Number : 205422

Product Number : 6

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

OTSUKA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BREXPIPRAZOLE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-913

Exclusivity Expiration Date

2026-05-10

Application Number

205422

Product Number

1

Exclusivity Details

02

OTSUKA

AAPS 2024

Not Confirmed

OTSUKA

Japan

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BREXPIPRAZOLE

Exclusivity Code : I-913

Exclusivity Expiration Date : 2026-05-10

Application Number : 205422

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

OTSUKA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BREXPIPRAZOLE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-14

Exclusivity Expiration Date

2027-05-08

Application Number

205422

Product Number

1

Exclusivity Details

03

OTSUKA

AAPS 2024

Not Confirmed

OTSUKA

Japan

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BREXPIPRAZOLE

Exclusivity Code : M-14

Exclusivity Expiration Date : 2027-05-08

Application Number : 205422

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

OTSUKA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BREXPIPRAZOLE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NPP

Exclusivity Expiration Date

2024-12-27

Application Number

205422

Product Number

1

Exclusivity Details

04

OTSUKA

AAPS 2024

Not Confirmed

OTSUKA

Japan

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BREXPIPRAZOLE

Exclusivity Code : NPP

Exclusivity Expiration Date : 2024-12-27

Application Number : 205422

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

OTSUKA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BREXPIPRAZOLE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-913

Exclusivity Expiration Date

2026-05-10

Application Number

205422

Product Number

4

Exclusivity Details

05

OTSUKA

AAPS 2024

Not Confirmed

OTSUKA

Japan

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BREXPIPRAZOLE

Exclusivity Code : I-913

Exclusivity Expiration Date : 2026-05-10

Application Number : 205422

Product Number : 4

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

OTSUKA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BREXPIPRAZOLE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NPP

Exclusivity Expiration Date

2024-12-27

Application Number

205422

Product Number

5

Exclusivity Details

06

OTSUKA

AAPS 2024

Not Confirmed

OTSUKA

Japan

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BREXPIPRAZOLE

Exclusivity Code : NPP

Exclusivity Expiration Date : 2024-12-27

Application Number : 205422

Product Number : 5

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

OTSUKA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BREXPIPRAZOLE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-14

Exclusivity Expiration Date

2027-05-08

Application Number

205422

Product Number

4

Exclusivity Details

07

OTSUKA

AAPS 2024

Not Confirmed

OTSUKA

Japan

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BREXPIPRAZOLE

Exclusivity Code : M-14

Exclusivity Expiration Date : 2027-05-08

Application Number : 205422

Product Number : 4

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

OTSUKA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BREXPIPRAZOLE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NPP

Exclusivity Expiration Date

2024-12-27

Application Number

205422

Product Number

4

Exclusivity Details

08

OTSUKA

AAPS 2024

Not Confirmed

OTSUKA

Japan

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BREXPIPRAZOLE

Exclusivity Code : NPP

Exclusivity Expiration Date : 2024-12-27

Application Number : 205422

Product Number : 4

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

OTSUKA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BREXPIPRAZOLE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-913

Exclusivity Expiration Date

2026-05-10

Application Number

205422

Product Number

6

Exclusivity Details

09

OTSUKA

AAPS 2024

Not Confirmed

OTSUKA

Japan

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BREXPIPRAZOLE

Exclusivity Code : I-913

Exclusivity Expiration Date : 2026-05-10

Application Number : 205422

Product Number : 6

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

OTSUKA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BREXPIPRAZOLE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-14

Exclusivity Expiration Date

2027-05-08

Application Number

205422

Product Number

6

Exclusivity Details

10

OTSUKA

AAPS 2024

Not Confirmed

OTSUKA

Japan

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BREXPIPRAZOLE

Exclusivity Code : M-14

Exclusivity Expiration Date : 2027-05-08

Application Number : 205422

Product Number : 6

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?